ExodusPoint Capital Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
VCM
VPM
ExodusPoint Capital Management's IDXX Position: Q1 2026 in Review
ExodusPoint Capital Management sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 22,386 shares — an estimated $15.1M sold.
ExodusPoint Capital Management first reported a position in IDXX in Q4 2018 and held it in 15 quarters. The position peaked at $23.1M in Q4 2024. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- ExodusPoint Capital Management reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
- ExodusPoint Capital Management sold 22,386 Idexx Laboratories shares in Q1 2026, an estimated $15.1M.
- ExodusPoint Capital Management first reported a position in Idexx Laboratories in Q4 2018 and held it in 15 quarters.
- ExodusPoint Capital Management's Idexx Laboratories position peaked at $23.1M in Q4 2024.
- 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.